首页> 外国专利> FUSION PROTEINS WITH SPECIFICITY FOR ED-B AND LONG SERUM HALF-LIFE FOR DIAGNOSIS OR TREATMENT OF CANCER

FUSION PROTEINS WITH SPECIFICITY FOR ED-B AND LONG SERUM HALF-LIFE FOR DIAGNOSIS OR TREATMENT OF CANCER

机译:融合蛋白具有ED-B和长血清半衰期的特异性,用于诊断或治疗癌症

摘要

The invention relates to fusion proteins comprising at least one extradomain B of fibronectin (ED-B) specific binding domain with high stability in serum and at least one APS domain essentially consisting of or consisting of up to about 80 amino acids selected from alanine, proline, serine, and optionally aspartic acid. The fusion protein further comprises at least one coupling site consisting of at least one cysteine. The invention relates to the use of the fusion proteins or of compositions comprising the fusion proteins for medical applications, such as diagnosis or treatment of cancer or cardiovascular diseases.
机译:本发明涉及融合蛋白,所述融合蛋白包括纤连蛋白(ED-B)特异性结合结构域的至少一种具有高稳定性的纤连蛋白(ED-B)特异性结合结构型,并且至少一种基本上由选自丙氨酸的丙氨酸的最多约80个氨基酸组成的APS结构域。 ,丝氨酸和任选的天冬氨酸。融合蛋白还包含至少一种由至少一种半胱氨酸组成的偶联位点。本发明涉及融合蛋白或包含用于医疗应用的融合蛋白的组合物的用途,例如癌症或心血管疾病的诊断或治疗。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号